Doreen Delaney
Surgical · Port Jefferson Station, NYNPI 1992723167
Payments from drug & device makers
What this record shows
This record is dominated by other: $17,350 of the $24,395 with a category attached, or 71.1%. Angiodynamics, Inc. accounts for 71.9% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $10,618 and has fallen 86.2% since, to $1,462 in 2025. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 219 payments — averaging $111.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$18K
- Abbott$3K
- Medtronic$2K
- Tactile Systems Technology Inc$1K
- Johnson & Johnson$506
- Silk Road Medical, Inc.$235
- plus $774 from 15 others
What the payments were for
- Food & beverage$7,04529%
- Other$17,35071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 6 | $17,546 |
| Abbott | 27 | $2,634 |
| Medtronic | 70 | $1,698 |
| Tactile Systems Technology Inc | 52 | $1,002 |
| Johnson & Johnson | 25 | $506 |
| Silk Road Medical, Inc. | 9 | $235 |
| AbbVie | 5 | $123 |
| Boston Scientific | 4 | $105 |
| Bard Peripheral Vascular, Inc. | 3 | $90 |
| Endologix LLC | 1 | $83 |
| Cook Medical LLC | 3 | $56 |
| Penumbra, Inc. | 4 | $51 |
| Integra Lifesciences Corporation | 1 | $47 |
| Organogenesis Inc. | 1 | $46 |
| Smith+Nephew | 2 | $32 |
| BD | 1 | $30 |
| 180 Medical, Inc. | 1 | $27 |
| Bioventus LLC | 1 | $23 |
| Biotronik Inc. | 1 | $21 |
| Acelrx Pharmaceuticals, Inc. | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,395 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 41 | $36,647 |
| EliquisApixaban | 15 | $12,322 |
| Cilostazol | 68 | $672 |
| ClopidogrelClopidogrel Bisulfate | 30 | $437 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $506 | $36,64741 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,544 surgical providers in New York.
Other surgical in Port Jefferson Station
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
- Tanya GeistAmherst$43K
- Irina KommNew York$39K
- Sarah MartineckWilliamsville$34K
- Richard DalabaAlbany$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.